The charities ACE and Lifeblood issue joint statement on access to new oral anticoagulants

Lifeblood and Anticoagulation Europe are both very concerned that the NICE recommendations that there should be equal access to VKAs (warfarin) and NOACs in the NICE approved indications are not being implemented. The NHS constitution states that patients should not be denied access to NICE approved drugs. And yet we know of many examples where patients starting anticoagulation, or those on long term anticoagulation who might wish to switch from warfarin, don’t appear to have been offered the opportunity to consider using a NOAC.

Read/download the joint statement:


You may also like...